When levels of secreted IL-1β and IL-18 were compared to aqueous-soluble SHIP1 levels in brain lysates, lower SHIP1 levels were signficantly associated with elevated IL-18 protein levels, with the correlation driven by data from AD brain tissue. The gene discussed is IL18; the disease is Alzheimer disease.